Objective of the study is to evaluate the effect of a multimodal therapy on the basis of
current guidelines on fall prevention consisting of a 12-months intervention with
Alfacalcidol and calcium, patient education and a mobility program in a group of patients 65
years of age or older with an impaired renal function in comparison to a group receiving
usual care.
Phase:
Phase 4
Details
Lead Sponsor:
Ruhr University of Bochum
Collaborators:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries